5- 6 "The securities represented by this certificate have not been registered under the U.S. Securities Act of 1933, as amended (the "Act"), and have been issued pursuant to an exemption from registration pursuant to Regulation S under the Act. These...Option Agreement • November 14th, 1996 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances)
1 EXHIBIT 10.55 AGREEMENT FOR CONSULTING SERVICES This Agreement is made by and between CytoTherapeutics, Inc. (the "Company") and Dr. Edwin C. Cadman (the "Consultant") as of September 2, 1996. 1. SERVICES. The Consultant shall provide to the Company...Consulting Agreement • November 14th, 1996 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Rhode Island
3- 4 5. Specific Performance. The rights of the parties under this Agreement are unique and, accordingly, the parties shall, in addition to such other remedies as may be available to any of them at law, have the right to enforce their rights hereunder...Stockholders Voting Agreement • November 14th, 1996 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances)
1 EXHIBIT 10.56 CONVERTIBLE LOAN AGREEMENT This Agreement dated as of July 10, 1996, is among Modex Therapeutiques SA, a Swiss corporation ("Modex") and CytoTherapeutics, Inc. ("CTI"), a Delaware corporation. CTI currently owns 6'500 shares of Modex...Convertible Loan Agreement • November 14th, 1996 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances)
ANDCross License Agreement • November 14th, 1996 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Rhode Island
2- 3 (c) CTI Repurchase of Subject Shares. In the event that, within two (2) years of the date hereof, any Individual Stockholder ceases to serve as a consultant to Modex as a result of the termination of such Individual Stockholder's consulting...Individual Stockholders Option Agreement • November 14th, 1996 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances)
